{
  "docId": "019de073-a38b-741c-ac33-1ee77869cf6c",
  "docSlug": "1556a4546991601fbfe098864d52433b",
  "documentTitle": "ATAI | Investor Presentation Deck | 36 slides",
  "authorId": "atai",
  "authorName": "atai Life Sciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 36,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 5,
  "notes": "The slide uses a numbered list to present five key pillars of the company's current status.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-a38b-741c-ac33-1ee77869cf6c/3",
  "deckHref": "/decks/019de073-a38b-741c-ac33-1ee77869cf6c",
  "deckJsonHref": "/decks/019de073-a38b-741c-ac33-1ee77869cf6c.json",
  "deckAnchorHref": "/decks/019de073-a38b-741c-ac33-1ee77869cf6c#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.9,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "list",
      "text": "1. Mental health disorders have become one of largest global health burdens. Depression rates of US adults saw a ~3x increase since the onset of the COVID-19 pandemic. 2. As a response to the technical risks associated with CNS drug development, atai focuses on compound classes with prior evidence in humans and utilizes a decentralized drug development process. 3. 12 active programs: 8 drug and discovery programs and 4 enabling technologies, focusing on differentiated, potentially disease-modifying therapies. 4. Validation of atai’s operating model: IPO of COMPASS Pathways and validating license deal between Otsuka & Perception. 5. We have a strong cash position of approx. $312M (as of June 30th, 2022) and access to up to $175m from term loan facility with Hercules, giving cash runway into 2025",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e0cc5cd4-d563-43f6-8e98-f8d03d2f65a2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.05,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "(1) THE COVID STATES PROJECT report (May 21, 2021)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "33ec91aa-c10c-448f-a263-b778787a7a8d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "atai Life Sciences: healing mental health disorders so that everyone everywhere can live a more fulfilled life",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7283823e-c3d0-4360-8e58-56bb02e5632f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "d9f307d9-1172-4aa2-a244-24a55acd4895",
      "evidence": "The slide provides an executive summary of the company's overview.",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "22550d14-b71c-47fa-b24f-43df4ad0d06b",
      "evidence": "Numbered list used to structure executive summary points",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}